Stay updated on XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check25 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check39 days agoChange DetectedThe page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the relevant date from '2024-10-15' to '2025-05-11'.SummaryDifference2%
- Check54 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
Stay in the know with updates to XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.